Industry News
Related Searches:
Filter by:
1216 - 1230 of 2389 results
Prev
80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
Next
December 10, 2009
Patheon will consolidate PR operations into Manati site, either losing or selling Caguas plant.
Read More »
December 9, 2009
Particle Sciences has expanded its HPC handling capabilities with help from IES Engineers.
Read More »
December 7, 2009
Celgene Corporation will acquire Gloucester Pharmaceuticals for $340 million in cash and as much as $300 million in milestone payments.
Read More »
December 3, 2009
Shri Thanedar, Ph.D., has been named chief executive officer of Azopharma Product Development Group.
Read More »
December 3, 2009
PPD, Inc. has launched a new global IT infrastructure for analysis and reporting of clinical trial data.
Read More »
December 2, 2009
VPI dedicated its new 24,000-sq.-ft. early development facility in Skokie, IL.
Read More »
November 30, 2009
Patheon's special committee and JLL partners have reached a settlement over their pending legal actions
Read More »
November 30, 2009
PPD completed its acquisition of BioDuro, a drug discovery outsourcing company
Read More »
November 20, 2009
The Almac Group has completed a 67,000-sq.-ft. expansion to its facility in Durham, NC, which now houses the company’s Clinical Services and Diagnostics Divisions.
Read More »
November 19, 2009
PPD, Inc. has signed an agreement to acquire BioDuro LLC, a drug discovery outsourcing company.
Read More »
November 18, 2009
Asterand has signed an agreement to acquire BioSeek Inc., a drug discovery services company, for $1.0 million payable in Asterand shares.
Read More »
November 18, 2009
Formatech has selected KAI Pharmaceuticals’ KAI-4169 compound as the second clinical candidate to receive “free” manufacturing services under its Fillanthropy Program.
Read More »
November 16, 2009
GlaxoSmithKline and Nabi Biopharmaceuticals entered an exclusive worldwide option and licensing agreement for nicotine conjugate candidate vaccine NicVAX, as well as for the development of a second generation nicotine vaccine.
Read More »
November 16, 2009
Sciele Pharma, Inc., a U.S.-based group of Shionogi & Co., Ltd., has entered an agreement to acquire and Addrenex Pharmaceuticals, a private, specialty pharmaceutical company, for approximately $29 million in cash.
Read More »
November 13, 2009
Abbott has entered into a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF).
Read More »
1216 - 1230 of 2389 results
Prev
80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
Next
